Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants
2021 · npj Vaccines · 58 citations
https://doi.org/10.1038/s41541-021-00337-0
P
Patricia Bourguignon
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
22
Papers
1.7K
Citations
15
h-index
18
i10-index
Patricia Bourguignon is an academic researcher from GlaxoSmithKline (Belgium). The author has contributed to research in topics: HIV Research and Treatment & Immune Cell Function and Interaction & Immunotherapy and Immune Responses. The author has an h-index of 15, co-authored 19 publications.
ORCID: 0000-0003-0398-6293Papers by this author
worksToxicology, biodistribution and shedding profile of a recombinant measles vaccine vector expressing HIV-1 antigens, in cynomolgus macaques
2012 · Naunyn-Schmiedeberg s Archives of Pharmacology · 26 citations
https://doi.org/10.1007/s00210-012-0793-4
Processing of blood samples influences PBMC viability and outcome of cell-mediated immune responses in antiretroviral therapy-naïve HIV-1-infected patients
2014 · Journal of Immunological Methods · 22 citations
https://doi.org/10.1016/j.jim.2014.09.001
Selection of HIV vaccine candidates for concurrent testing in an efficacy trial
2016 · Current Opinion in Virology · 14 citations
https://doi.org/10.1016/j.coviro.2016.01.007
Author Correction: Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity
2018 · npj Vaccines · 3 citations
https://doi.org/10.1038/s41541-018-0047-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat